These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 19657571)
1. SKP2 siRNA inhibits the degradation of P27kip1 and down-regulates the expression of MRP in HL-60/A cells. Xiao J; Yin S; Li Y; Xie S; Nie D; Ma L; Wang X; Wu Y; Feng J Acta Biochim Biophys Sin (Shanghai); 2009 Aug; 41(8):699-708. PubMed ID: 19657571 [TBL] [Abstract][Full Text] [Related]
2. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein. Huang HC; Way TD; Lin CL; Lin JK Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023 [TBL] [Abstract][Full Text] [Related]
3. Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer. Uddin S; Ahmed M; Hussain AR; Jehan Z; Al-Dayel F; Munkarah A; Bavi P; Al-Kuraya KS Lab Invest; 2009 Oct; 89(10):1115-27. PubMed ID: 19636294 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. Katagiri Y; Hozumi Y; Kondo S J Dermatol Sci; 2006 Jun; 42(3):215-24. PubMed ID: 16504485 [TBL] [Abstract][Full Text] [Related]
5. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456 [TBL] [Abstract][Full Text] [Related]
6. Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway. Foster JS; Fernando RI; Ishida N; Nakayama KI; Wimalasena J J Biol Chem; 2003 Oct; 278(42):41355-66. PubMed ID: 12904306 [TBL] [Abstract][Full Text] [Related]
7. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389 [TBL] [Abstract][Full Text] [Related]
8. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165 [TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2. Su B; Chen X; Zhong C; Guo N; He J; Fan Y J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541 [TBL] [Abstract][Full Text] [Related]
10. S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma. Uddin S; Hussain A; Ahmed M; Belgaumi A; Al-Dayel F; Ajarim D; Bavi P; Al-Kuraya KS J Pathol; 2008 Dec; 216(4):483-94. PubMed ID: 18850583 [TBL] [Abstract][Full Text] [Related]
11. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556 [TBL] [Abstract][Full Text] [Related]
12. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859 [TBL] [Abstract][Full Text] [Related]
13. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing]. Lian C; Yang J; Wang X; Xie Y; Xiao Q Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275 [TBL] [Abstract][Full Text] [Related]
14. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140 [TBL] [Abstract][Full Text] [Related]
15. Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2. Koo KH; Kim H; Bae YK; Kim K; Park BK; Lee CH; Kim YN Cell Death Dis; 2013 Jun; 4(6):e693. PubMed ID: 23807222 [TBL] [Abstract][Full Text] [Related]
16. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996 [TBL] [Abstract][Full Text] [Related]
17. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells. Supriatno ; Harada K; Yoshida H; Sato M Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. Lee SH; McCormick F J Mol Med (Berl); 2005 Apr; 83(4):296-307. PubMed ID: 15605273 [TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. Liu Z; Fu Q; Lv J; Wang F; Ding K J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157 [TBL] [Abstract][Full Text] [Related]
20. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma. Keikhaee MR; Kudo Y; Siriwardena S; Wu L; Ogawa I; Takata T Virchows Arch; 2007 May; 450(5):567-74. PubMed ID: 17431674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]